Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIR2.6 Activators

Chemical activators of KIR2.6 can engage various intracellular signaling pathways to modulate the activity of this potassium channel. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which is a key player in phosphorylating target proteins such as KIR2.6, leading to its activation. PKC can also be activated indirectly by other chemical activators. For example, 1-Ethyl-2-benzimidazolinone enhances the activity of cyclic AMP (cAMP), which in turn activates protein kinase A (PKA). PKA then phosphorylates KIR2.6, resulting in its activation. Similarly, Dibucaine inhibits phosphodiesterases, leading to increased levels of cAMP and subsequent activation of PKA, which may activate KIR2.6. Minaprine also increases cAMP levels but does so by activating adenylyl cyclase, setting off a cascade that results in the activation of PKA and subsequent phosphorylation of KIR2.6.

Other chemical activators exert their effects by altering intracellular calcium dynamics. FPL 64176 and Bay K 8644 are calcium channel activators that increase intracellular calcium concentrations, which may activate calcium-dependent potassium channels such as KIR2.6. Zinc Pyrithione and Ciclopirox also elevate intracellular calcium levels, which could activate calcium/calmodulin-dependent protein kinase II (CaMKII), potentially leading to the activation of KIR2.6. NS 1619, a BK channel activator known for increasing calcium sensitivity, can similarly activate KIR2.6 by enhancing its calcium sensitivity. Sevoflurane can potentiate the effect of GABA, leading to membrane hyperpolarization, which in turn could trigger the activation of KIR2.6. Pioglitazone, which acts on PPAR-gamma, may alter the transcription of proteins that regulate potassium channels, thereby influencing the activity of KIR2.6. Finally, Tertiapin-Q, by selectively blocking certain potassium channels, may indirectly cause an upregulation and activation of KIR2.6 as the cell attempts to maintain ionic balance. Each of these chemicals, through their distinct mechanisms, can contribute to the activation of KIR2.6.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which is known to phosphorylate a wide range of target proteins, including ion channels like KIR2.6, leading to their activation.

1-EBIO

10045-45-1sc-201695
sc-201695A
10 mg
50 mg
$87.00
$325.00
1
(1)

1-Ethyl-2-benzimidazolinone enhances the activity of cyclic AMP (cAMP), which can lead to the activation of PKA. PKA then can phosphorylate and activate potassium channels such as KIR2.6.

FPL-64176

120934-96-5sc-201491
5 mg
$83.00
1
(1)

FPL 64176 acts as a calcium channel activator, which can lead to an increased intracellular calcium concentration, indirectly causing the activation of calcium-dependent potassium channels like KIR2.6.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Zinc Pyrithione is known to increase the intracellular calcium concentration, which can activate calcium/calmodulin-dependent protein kinase II (CaMKII), potentially leading to the activation of KIR2.6.

Ciclopirox

29342-05-0sc-217893
25 mg
$207.00
2
(1)

Ciclopirox causes an increase in intracellular calcium levels which may activate calcium-dependent pathways, potentially leading to the activation of potassium channels like KIR2.6.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Pioglitazone, through its agonist activity on PPAR-gamma, may lead to altered transcription of proteins that regulate potassium channel activity, thus indirectly leading to the activation of KIR2.6.

(±)-Bay K 8644

71145-03-4sc-203324
sc-203324A
sc-203324B
1 mg
5 mg
50 mg
$84.00
$196.00
$817.00
(0)

Bay K 8644 is an L-type calcium channel activator, which may indirectly increase intracellular Ca2+ levels, potentially leading to the activation of Ca2+-sensitive proteins that could activate KIR2.6.